Biotech

BD Launches Portable Antigen Test to Detect SARS-CoV-2 in 15 Minutes

NEW JERSEY BUSINESS MAGAZINE

BD (Becton, Dickinson and Company), a Franklin Lakes-based global medical technology company, announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor™ Plus System. The launch of this new assay that delivers results in 15 minutes on an easy-to-use, highly portable …

Shade, working out of CDI, gets $750K grant for wearable that measures strength of UV rays

Tom Bergeron | ROI-NJ.COM

A wearable that can measure the UV index from sunlight soon could be mainstream — thanks to a $750,000 grant from the National Science Foundation. The product, which fits on your wrist and is in the shape of an old-school watch, is produced by Shade, which works out of the Center for Discovery & Innovation, a research arm of Hackensack …

New Jersey Solutions For Cell And Gene Development and Manufacturing

Louis Garguilo | Outsourced Pharma

New Jersey’s first university-based, cell-and-gene-therapy development and manufacturing innovation center for-hire, was founded on the answers to these questions of the biopharma industry: What are your main challenges in manufacturing gene and cell therapy products? What are your challenges in recruiting talent? What do you need to effectively train your current employees? Answers poured in pre-establishment of the center from …

China-Based WuXi Biologics Selects Cranbury, New Jersey for Third U.S. Clinical Manufacturing Campus

Area Development News Desk | Area Development

WuXi Biologics, a China-based global company with leading open-access biologics technology platforms, signed a 10-year lease for a clinical manufacturing facility in Cranbury, New Jersey. This news follows WuXi Biologics’ recent purchase of land to build a new 107,000-square-foot clinical and commercial manufacturing facility in Worcester, Massachusetts, and the lease of a 33,000-square-foot site to establish a process development lab …

Merck Does Deals to Develop Coronavirus Vaccines, Drug

Jared S. Hopkins | The Wall Street Jounrnal

Big drugmaker Merck MRK -0.36%  & Co. said it is working on two potential vaccines and an experimental drug against the coronavirus, joining rivals in the frantic search for medicines. Merck, one of the world’s largest pharmaceutical companies by sales, said Tuesday it is acquiring one experimental vaccine as part of the purchase of its Austrian maker, while partnering in …

World’s First SARS-CoV-2 Serology Test Detects Neutralizing Antibodies Without Containment Facility or Specimen

HospiMedica

Researchers have developed the world’s first serological coronavirus detection system that allows for rapid detection of neutralizing antibodies (NAbs) present in the serum of COVID-19 patients without the need for live biological materials and biocontainment facility. GenScript Biotech Corporation (Piscataway, NJ, USA), Duke-NUS Medical School, and the Diagnostics Development Hub (DxD) at Singapore’s Agency for Science, Technology and Research (A*STAR) …

Rutgers University Launches the Nation’s Largest Study of Health Care Workers Exposed to COVID-19

Patti Verbanas | Rutgers

More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital are participating in a pioneering study Rutgers University announced today that it has launched the nation’s largest prospective study of health care workers exposed to COVID-19. The study includes a series of clinical trials that will explore new drug treatments, antibody testing, and long-term health tracking …

Visikol expands headquarters with Hunterdon County move

Linda Lindner | NJBIZ

To kick off the new year, Visikol announced it expanded its footprint in New Jersey by moving its headquarters to a 6,400-square-foot space in Hampton, with room to grow. The new facility will be in the Perryville III building – a 288,000-square-foot class A office building off Interstate 78. What started off as a university spin-out from Rutgers University almost …

New Jersey Reclaiming its Position as America’s Life Sciences Capital

Jose Lozano | Expansion Solutions Magazine

With a 150-year history of developing lifesaving medicine, New Jersey has always been the capital of innovation. We welcome big ideas and those who think differently to bring transformative therapies, novel medicines and disruptive technologies to market. The state’s innovation economy includes strong industry synergy, venture capital funding, access to leading universities, proximity to research hospitals and concentration of top …

WHAT CAN CHOOSE New Jersey DO FOR YOU

Relocation & Expansion Services

We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.

Site Visits

We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.

Economic Development Connections

Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.

Carly Wronko
Marketing Manager
Tiffany Hess-Bennette
Creative Content Specialist